| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
|
Massy, Ziad A.
|
|
|
4 |
11 |
p. 1546-1554
|
artikel
|
| 2 |
Association Between Perfluoroalkyl Substance Exposure and Renal Function in Children With CKD Enrolled in H3Africa Kidney Disease Research Network
|
Sood, Shefali
|
|
|
4 |
11 |
p. 1641-1645
|
artikel
|
| 3 |
Eculizumab Safety: Five-Year Experience From the Global Atypical Hemolytic Uremic Syndrome Registry
|
Rondeau, Eric
|
|
|
4 |
11 |
p. 1568-1576
|
artikel
|
| 4 |
Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis
|
Mendoza, Carmen E.
|
|
|
4 |
11 |
p. 1617-1629
|
artikel
|
| 5 |
Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies
|
Drachenberg, Cinthia B.
|
|
|
4 |
11 |
p. 1555-1567
|
artikel
|
| 6 |
Evaluation of Different Dialyzers and the Impact of Predialysis Albumin Priming in Intermittent Hemodialysis With Reduced Anticoagulation
|
Vanommeslaeghe, Floris
|
|
|
4 |
11 |
p. 1538-1545
|
artikel
|
| 7 |
Geographic Variation in the Availability of Deceased Donor Kidneys per Wait-Listed Candidate in the United States
|
King, Kristen L.
|
|
|
4 |
11 |
p. 1630-1633
|
artikel
|
| 8 |
Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)
|
Barratt, Jonathan
|
|
|
4 |
11 |
p. 1633-1637
|
artikel
|
| 9 |
2017 Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update Implementation: Asia Summit Conference Report
|
Wang, Angela Yee-Moon
|
|
|
4 |
11 |
p. 1523-1537
|
artikel
|
| 10 |
Membranous Glomerulonephritis With Crescents
|
Nikolopoulou, Aikaterini
|
|
|
4 |
11 |
p. 1577-1584
|
artikel
|
| 11 |
Predialysis Care Experience Among Patients With CKD at a Teaching Hospital in Kenya
|
Kabinga, Samuel K.
|
|
|
4 |
11 |
p. 1638-1641
|
artikel
|
| 12 |
Role of Liver Transplantation in Tolvaptan-Associated Acute Liver Failure
|
Endo, Mayumi
|
|
|
4 |
11 |
p. 1653-1657
|
artikel
|
| 13 |
Sotatercept Safety and Effects on Hemoglobin, Bone, and Vascular Calcification
|
Coyne, Daniel W.
|
|
|
4 |
11 |
p. 1585-1597
|
artikel
|
| 14 |
Spontaneous Renal Artery Dissection in Ehler–Danlos Syndrome
|
Emanuela, Cataldo
|
|
|
4 |
11 |
p. 1649-1652
|
artikel
|
| 15 |
Steroid-Associated Side Effects in Patients With Primary Proteinuric Kidney Disease
|
Oh, Gia J.
|
|
|
4 |
11 |
p. 1608-1616
|
artikel
|
| 16 |
The Authors Reply
|
Duval, Anna
|
|
|
4 |
11 |
p. 1658-1659
|
artikel
|
| 17 |
The Executive Order on Kidney Care: An Opportunity to Improve Outcomes for Individuals With Kidney Disease
|
Pearson, Jeffrey
|
|
|
4 |
11 |
p. 1519-1522
|
artikel
|
| 18 |
The Executive Order on Kidney Care: We Need to Do Much More to Win the Battle Against Kidney Disease
|
Handal, Janet
|
|
|
4 |
11 |
p. 1515-1518
|
artikel
|
| 19 |
Use of Eculizumab During Pregnancy in Kidney Transplant Recipients With Atypical HUS
|
Cheung, Chee Kay
|
|
|
4 |
11 |
p. 1658
|
artikel
|
| 20 |
Vascular Ehlers-Danlos Syndrome Diagnosed in a Patient Initiating Hemodialysis
|
Ouchi, Haruki
|
|
|
4 |
11 |
p. 1646-1648
|
artikel
|
| 21 |
Vitamin D Metabolic Ratio and Risks of Death and CKD Progression
|
Bansal, Nisha
|
|
|
4 |
11 |
p. 1598-1607
|
artikel
|
Tijdschrift beschrijving